7-2539223-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_152743.4(BRAT1):​c.1726G>A​(p.Gly576Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0141 in 1,610,692 control chromosomes in the GnomAD database, including 200 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G576A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.011 ( 17 hom., cov: 33)
Exomes 𝑓: 0.014 ( 183 hom. )

Consequence

BRAT1
NM_152743.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.03

Publications

7 publications found
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]
BRAT1 Gene-Disease associations (from GenCC):
  • neonatal-onset encephalopathy with rigidity and seizures
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with cerebellar atrophy and with or without seizures
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00877741).
BP6
Variant 7-2539223-C-T is Benign according to our data. Variant chr7-2539223-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 472954.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0113 (1724/152332) while in subpopulation NFE AF = 0.0163 (1108/68034). AF 95% confidence interval is 0.0155. There are 17 homozygotes in GnomAd4. There are 832 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRAT1NM_152743.4 linkc.1726G>A p.Gly576Ser missense_variant Exon 13 of 14 ENST00000340611.9 NP_689956.2 Q6PJG6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRAT1ENST00000340611.9 linkc.1726G>A p.Gly576Ser missense_variant Exon 13 of 14 1 NM_152743.4 ENSP00000339637.4 Q6PJG6-1

Frequencies

GnomAD3 genomes
AF:
0.0113
AC:
1725
AN:
152214
Hom.:
17
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00275
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0137
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00579
Gnomad FIN
AF:
0.0159
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0163
Gnomad OTH
AF:
0.0125
GnomAD2 exomes
AF:
0.0115
AC:
2828
AN:
244884
AF XY:
0.0122
show subpopulations
Gnomad AFR exome
AF:
0.00281
Gnomad AMR exome
AF:
0.00877
Gnomad ASJ exome
AF:
0.0163
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0155
Gnomad NFE exome
AF:
0.0155
Gnomad OTH exome
AF:
0.0129
GnomAD4 exome
AF:
0.0143
AC:
20926
AN:
1458360
Hom.:
183
Cov.:
32
AF XY:
0.0142
AC XY:
10301
AN XY:
725374
show subpopulations
African (AFR)
AF:
0.00227
AC:
76
AN:
33414
American (AMR)
AF:
0.00868
AC:
388
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0158
AC:
413
AN:
26110
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39686
South Asian (SAS)
AF:
0.00782
AC:
674
AN:
86150
European-Finnish (FIN)
AF:
0.0154
AC:
804
AN:
52120
Middle Eastern (MID)
AF:
0.00632
AC:
28
AN:
4430
European-Non Finnish (NFE)
AF:
0.0159
AC:
17717
AN:
1111564
Other (OTH)
AF:
0.0137
AC:
822
AN:
60192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1280
2560
3839
5119
6399
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0113
AC:
1724
AN:
152332
Hom.:
17
Cov.:
33
AF XY:
0.0112
AC XY:
832
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00274
AC:
114
AN:
41578
American (AMR)
AF:
0.0137
AC:
209
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00579
AC:
28
AN:
4834
European-Finnish (FIN)
AF:
0.0159
AC:
169
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0163
AC:
1108
AN:
68034
Other (OTH)
AF:
0.0123
AC:
26
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
92
184
275
367
459
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0134
Hom.:
23
Bravo
AF:
0.0109
TwinsUK
AF:
0.0132
AC:
49
ALSPAC
AF:
0.0182
AC:
70
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.0185
AC:
159
ExAC
AF:
0.0114
AC:
1386
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.0147
EpiControl
AF:
0.0148

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Sep 16, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neonatal-onset encephalopathy with rigidity and seizures Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neonatal-onset encephalopathy with rigidity and seizures;C4748032:Neurodevelopmental disorder with cerebellar atrophy and with or without seizures Benign:1
Oct 05, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 31, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
17
DANN
Benign
0.94
DEOGEN2
Benign
0.00065
T
Eigen
Benign
-0.069
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.0088
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
L
PhyloP100
2.0
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.51
N
REVEL
Benign
0.098
Sift
Benign
0.44
T
Sift4G
Benign
1.0
T
Polyphen
1.0
D
Vest4
0.20
MPC
0.29
ClinPred
0.015
T
GERP RS
4.9
Varity_R
0.061
gMVP
0.15
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61740320; hg19: chr7-2578857; API